Table: begin end state 1 11 non-cytoplasmic 12 35 transmembrane 36 41 cytoplasmic 42 71 transmembrane 72 76 non-cytoplasmic 77 97 transmembrane 98 108 cytoplasmic 109 133 transmembrane 134 139 non-cytoplasmic 140 140 transmembrane 141 142 non-cytoplasmic 143 162 transmembrane 163 168 cytoplasmic 169 190 transmembrane 191 201 non-cytoplasmic 202 223 transmembrane 224 261 cytoplasmic 262 283 transmembrane 284 324 non-cytoplasmic 325 346 transmembrane 347 357 cytoplasmic 358 381 transmembrane 382 392 non-cytoplasmic 393 410 transmembrane 411 416 cytoplasmic 417 447 transmembrane 448 467 non-cytoplasmic 468 488 transmembrane 489 505 cytoplasmic
Input: >3609738 MLEGLLIGLQTAFSIQNLAMVIGGCLIGTFIGMLPGLGPMSIIAIMIPVAISLGDPSAAL ILLAGVYYGAIFGGSTSSILLNAPGVAGTVATSFDGYPMAQQGKAGKALTIAAIASFAGG TIGAILLMVFAPALSSVALLFHSAEYFALMVVGLSAIAAFAGTGQVAKALLMTILGLIMA TVGEGALFASPRFTMGLMDLQSGFGFITLAMAMFALPEALFLVMNPLRAASGQGGGEIKD LRITRAEARSIAPVIGRQSVQGFFIGVLPGAGATIASFLGYAVERNIASKDEQAEFGKGS VKGLAAPETANNAACTGSFVPLLTLGIPGSGTTAILLGALLALNVSPGPRLMIDAPEIFW AVIMSMFIGNLVLLILNLPLIPYIAKILSVPRNYLIPFILFFTLMGAYIGQNNATELLLL VGFGICATILKFADYPLAPLLIGFILGGLLENNFSRAMQLYDGISFIWERPMTLGLLVIA ALLIILPSYRNRRAKARAAGVADGD
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server